Groundbreaking HIV study launches

Wednesday, November 30, 2016

The Botswana Harvard AIDS Institute Partnership (BHP) yesterday launched its inaugural clinical study to look into the effectiveness of antibodies in reducing the acquisition of HIV among high-risk female populations.The research explores a new idea for HIV prevention, investigators explained on Tuesday.

The study, which started in July, targets a maximum of 300 women aged between 18-40 among whom the HIV incidence is leading in sub-Saharan Africa, in addition to glaring disproportions among their male counterparts.

For instance, HIV incidence among 15 to 19-year-olds is reported to be three percent for males, and much more for females at seven percent.

Already have an active account? Log in here.

Or Sign up and get unlimited access to premium articles.

VP Lesang, Seretse dump BPF

Tsaone Basimanebotlhe | 15 m ago

The SADC summit and the silent diplomacy

Selefu | 3 h ago

Forbes Under 30 returns to Botswana

Sharon Mathala | 4 h ago

BDP welcomes Lesaso, recruits 94

Tsaone Basimanebotlhe | 6 h ago

In the nick of time!

Selefu | 1d ago

Softball squad for World Cup qualifies released

Staff Writer | 1d ago

Isolated home invasions hit Tsholofelo East, Phakalane

Pini Bothoko | 2d ago

Constitutional review

Selefu | 1d ago

Tighten the law on drug dealers

Our youth are perishing; their once hopeful bright future is going down the drain; all because of illicit drugs.It is very easy to blame the addict, but it is not as simple as that! Drug dealing is a very lucrative business for some shameless people amongst our society and as such they have come up with tight strategies on how to push their business.Drug addiction is bad, and while the individual on drugs sometimes might have been the one who...

The Monitor Editor | 30 January 2023

About us

Mmegi is the leading independent source of breaking news, latest news, current
affairs, Politics, Business, Sport, debates, analysis, and entertainment news in Botswana.

Explore

More